Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Says QPCR, Reagent Sales Will Drive 7-Percent Growth in Q4 Revenue

NEW YORK (GenomeWeb News) — Stratagene today said it expects fourth-quarter revenue to be around $24.7 million, or 7 percent better than last year’s pro forma revenue of $23 million for the same period.
The uptick came largely from sales of the company’s QPCR products and reagents, which were up 7 percent, and from allergy diagnostics products, which were up 23 percent, Stratagene said.
However, Stratagene said it expects these increases to be offset by an expected drop in sales of its gene-discovery and cloning products.  
Stratagene did not say how much it expects these legacy sales to decrease, but EO Joseph Sorge said the company believes market growth for molecular and clinical diagnostics will “provide sizeable, long-term profitable revenue growth opportunities. …”

The company expects to release final fourth quarter and full year results in early March 2007. 

In the fourth quarter of 2005, Stratagene received a one-time payment of $34.1 million from Cambridge Antibody Technology for patent interests, which boosted total revenue to $57.1 million.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.